Search For "glenmark pharmaceuticals ltd"
Glenmark launches 'Hello Skin' - India's first Whatsapp based chatbot to h
Updated : 4 years ago IST
Mumbai (Maharashtra) [India], May 24 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark), an innovation-led global pharmaceutical company, has developed a digital patient education tool, 'Hello Skin' in collaboration with the IADVL (Indian Association of Dermatologists, Venereologists
Read More
Glenmark receives the 'India Pharma Innovation of the Year' Award from the
Updated : 4 years ago IST
Mumbai (Maharashtra) [India], April 27 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global pharmaceutical company, today received the 'India Pharma Innovation of the Year' Award and was adjudged runners-up in the 'India Pharma CSR of the Year' category, a
Read More
Glenmark Specialty S.A. and Lotus International Pte. Ltd. enter into exclu
Updated : 4 years, 4 months ago IST
Mumbai (Maharashtra) [India], January 20 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global, integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agreement with Lot
Read More
Glenmark Pharmaceuticals makes it to the prestigious Dow Jones Sustainabil
Updated : 4 years, 6 months ago IST
Mumbai (Maharashtra) [India], November 16 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that the company has been listed in the Dow Jones Sustainability Index (DJSI), under the category of emerging markets
Read More
Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate
Updated : 4 years, 8 months ago IST
Mumbai (Maharashtra) [India], September 21 (ANI/PR Newswire): Glenmark Pharmaceuticals Ltd. (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Clindamycin Phosphate Foam, 1%, the generic version of Evoclin®1 Foam, 1%, of Mylan Pharm
Read More
Fitch affirms Glenmark Pharmaceuticals at BB on IPO of API business
Updated : 4 years, 9 months ago IST
Singapore, August 10 (ANI): Fitch Ratings has affirmed Glenmark Pharmaceuticals Ltd's long-term issuer default rating at BB after its active pharmaceutical ingredient (API) business completed an initial public offering (IPO).
Read More
Fitch affirms Glenmark Pharmaceuticals at BB with stable outlook
Updated : 4 years, 10 months ago IST
Singapore, July 6 (ANI): Fitch Ratings has affirmed Glenmark Pharmaceuticals Ltd's long-term issuer default rating at BB with a stable outlook.
Read More
Glenmark Pharmaceuticals receives ANDA tentative approval for Nintedanib C
Updated : 4 years, 11 months ago IST
Mumbai (Maharashtra) [India], June 25 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark) has received tentative approval by the United States Food & Drug Administration (U.S. FDA) for Nintedanib Capsules, 100 mg and 150 mg, the generic version of Ofev®1 Capsules, 100 mg and 1
Read More
Glenmark Pharmaceuticals receives ANDA approval for Arformoterol Tartrate
Updated : 4 years, 11 months ago IST
Mumbai (Maharashtra) [India], June 23 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit-Dose Vials, the generic version of BROVA
Read More
Glenmark Pharmaceuticals receives ANDA approval for Theophylline Extended-
Updated : 4 years, 11 months ago IST
Mumbai (Maharashtra) [India], June 4 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Theophylline Extended-release Tablets, 300 mg and 450 mg, bioequivalent and therapeutically equivalent
Read More
Glenmark Pharma approves Rs 1,160 crore IPO from subsidiary Glenmark Life
Updated : 5 years, 1 month ago IST
Mumbai (Maharashtra) [India], Apr 19 (ANI): Glenmark Life Sciences Ltd, a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd, has filed a draft red herring prospectus with the Securities and Exchange Board of India for an initial public offer (IPO) to raise Rs 1,160 crore.
Read More
Glenmark's Ryaltris- innovative single nasal spray, ready to market in Rus
Updated : 5 years, 3 months ago IST
Mumbai (Maharashtra) [India], February 22 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty SA, received marketing approval from the Ministry of Health of the Russ
Read More